Literature DB >> 12970745

The relationship between connexins, gap junctions, tissue architecture and tumour invasion, as studied in a novel in vitro model of HPV-16-associated cervical cancer progression.

Trond Aasen1, Malcolm B Hodgins, Michael Edward, Sheila V Graham.   

Abstract

Disruption of gap junctional intercellular communication (GJIC) and/or connexins (gap junction proteins) is frequently reported in malignant cell lines and tumours. Certain human papillomaviruses (HPV) associated with the development of cancers, especially of the cervix, have previously been reported to downregulate GJIC in vitro. There is also evidence for reduced gap junctions in cervical dysplasia. However, many squamous hyperproliferative conditions, including HPV-induced warts, often show extensive upregulation of certain connexins. The association between HPV and GJIC, and the mechanism and consequence of deregulated GJIC in cervical tumour progression, remains unclear. Therefore, using a variety of nonmalignant and malignant cell lines and an organotypic raft-culture system, we investigated the relationship between HPV, gap junctions and tumour progression. Established cervical tumour cell lines carrying HPV were unable to communicate via gap junctions (when assayed by dye-transfer techniques). This correlated with lack of connexin protein expression, while transfection with connexins 26 or 43 led to functional gap junction membrane plaques. On the other hand, immortal but nonmalignant cell lines that contained episomal or integrated HPV-16, but required feeder-layer and growth-factor support, were consistently well coupled, and expressed multiple connexins at membrane junctions. In vitro selection of feeder-layer and growth-factor-independent variants eventually lead to loss of GJIC, which correlated with loss of membrane and increased cytoplasmic connexin 43 localization. However, this was preceded by loss of differentiation and stromal invasion, as assayed on the organotypic raft-culture model. Using this model, a comparison between noncoupled, well-coupled and connexin-transfected cell lines revealed no firm correlation between GJIC and dysplasia, but GJIC appeared to favour increased stratification. These findings demonstrate that loss of GJIC is frequent, but appears to occur more as a consequence of, rather than being the cause of, epithelial dysplasia, and may be influenced by, but is not directly attributable to, HPV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970745     DOI: 10.1038/sj.onc.1206709

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  Gap junctional communication in morphogenesis.

Authors:  Michael Levin
Journal:  Prog Biophys Mol Biol       Date:  2007-03-16       Impact factor: 3.667

2.  GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.

Authors:  Xiaoming Liu; Ke Cao; Canxia Xu; Tingzi Hu; Li Zhou; Dan Cao; Jing Xiao; Ling Luo; Yinjie Guo; Yong Qi
Journal:  Cancer Biol Ther       Date:  2015-04-22       Impact factor: 4.742

3.  Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.

Authors:  L Kanczuga-Koda; S Sulkowski; A Lenczewski; M Koda; A Wincewicz; M Baltaziak; M Sulkowska
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

4.  Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).

Authors:  Melanie McFarlane; Alasdair I MacDonald; Andrew Stevenson; Sheila V Graham
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

5.  Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type.

Authors:  Lee B Sims; Keegan C Curry; Sindhu Parupalli; Gwynneth Horner; Hermann B Frieboes; Jill M Steinbach-Rankins
Journal:  Pharm Res       Date:  2019-03-13       Impact factor: 4.200

6.  Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation.

Authors:  Karthikeyan Veeraraghavalu; Mark Pett; Rekha V Kumar; Pradip Nair; Annapoorni Rangarajan; Margaret A Stanley; Sudhir Krishna
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Connexin43 Expression Increases in the Epithelium and Stroma along the Colonic Neoplastic Progression Pathway: Implications for Its Oncogenic Role.

Authors:  Yusheng Han; Paul J Zhang; Terina Chen; Sabrina W Yum; Teresa Pasha; Emma E Furth
Journal:  Gastroenterol Res Pract       Date:  2011-06-30       Impact factor: 2.260

8.  Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Authors:  Sarah Mole; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

9.  RNA splicing factors regulated by HPV16 during cervical tumour progression.

Authors:  Sarah Mole; Melanie McFarlane; Thanaporn Chuen-Im; Steven G Milligan; David Millan; Sheila V Graham
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

10.  The Role of Bystander Effects in the Antitumor Activity of the Hypoxia-Activated Prodrug PR-104.

Authors:  Annika Foehrenbacher; Kashyap Patel; Maria R Abbattista; Chris P Guise; Timothy W Secomb; William R Wilson; Kevin O Hicks
Journal:  Front Oncol       Date:  2013-10-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.